CD96 is a specific marker of leukemia stem cells in human AML, which is a good candidate target for targeting LSC (Hosen et al., 2007; Wang et al., 2013; Ding et al., 2017; Jiang et al., 2017). The gene discussed is CD96; the disease is acute myeloid leukemia.